Bavarian Nordic secures second part of smallpox vaccine order from the US
The order, which was made public in April 2020, is worth USD 200m.
BY RITZAU FINANS, TRANSLATED BY NIELSINE NIELSEN
Bavarian Nordic has secured the second part of a smallpox vaccine order from the US government, as Biomedical Advanced Research and Development Authority (BARDA) has exercised an option. Bavarian Nordic announces this on Wednesday evening.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Media: Europe aims for vaccine approval on Dec. 23
For subscribers
Coronavirus vaccines are lucrative business
For subscribers
.jpg&w=384&q=75)
